Rapamycin and Longevity in Germany

Rapamycin (also called sirolimus) is a drug first pulled from a soil bacterium called Streptomyces hygroscopicus on Easter Island (Rapa Nui). It has been approved since 1999, originally to suppress the immune system after a kidney transplant.

How it works: Rapamycin blocks a protein complex called mTOR (a cellular switch that senses nutrients), specifically the mTORC1 version. mTOR runs cell growth, protein building, and autophagy (the cell's way of cleaning out its own junk).

Why the longevity crowd cares: In animal studies, no other substance has extended lifespan as reliably as rapamycin. Mice, flies, worms, and yeast all lived 10 to 25 percent longer on it.

One thing to be clear about: Rapamycin is not a longevity supplement. It is a prescription drug that really does suppress the immune system and bring other side effects. Any off-label use carries real risks.

This guide is not medical advice.

The mTOR longevity idea goes like this:

1. mTOR is an old nutrient-surplus sensor. Lots of food flips it on. 2. Keeping mTOR high for too long speeds up aging. It shuts down autophagy and feeds zombie cells (old cells that refuse to die and cause inflammation). 3. Anything that dials mTOR down extends animal lifespan: eating less, fasting, rapamycin. 4. Rapamycin is the most direct mTOR dial-down, with a dose you can control.

Mouse trials (NIH Intervention Testing Program): - Rapamycin in older mice added 9 to 14 percent to median lifespan, even when started late in life (Harrison et al., Nature, 2009) - The effect held up across different mouse strains - The more given, the bigger the effect

The big open questions for people: - Humans already age 30 to 50 times slower than mice. A 15 percent bump on a 2-year mouse life does not automatically mean 15 percent on 80 years. - Suppressing the immune system at age 70, with real infections around, is a real concern. - Every day vs. once a week: newer protocols use low weekly doses to cut immune effects. The evidence is still thin.

Human data on rapamycin for longevity is much thinner than animal data.

Direct longevity trials in people: - PEARL study (AgelessRx/Lifespan.io, results October 2024, with Kaeberlein as scientific advisor): randomized placebo-controlled trial of low-dose rapamycin over 12 months in healthy adults. The primary endpoint (change in biological age markers) was not clearly met. Sex-specific secondary signals in women (lean mass, pain reduction). Peer-reviewed publication: available as preprint. - Lower-dose trials: Mannick et al. (Science Translational Medicine 2014 & 2018, with RAD001/everolimus) found better immune function in older adults at 1 to 6 mg per week.

What we see in transplant patients: - People on rapamycin after a transplant get less skin cancer, and possibly fewer of some other cancers. - This does not translate cleanly to longevity use.

Most common side effects at longevity doses (5 to 6 mg per week): - Mouth ulcers (the most frequent) - Occasional signs of a weakened immune response - Higher blood fats - Higher blood sugar - Interactions with many drugs (via the liver enzyme CYP3A4)

What we still do not know: - Long-term safety over 10 or more years in healthy adults - The best dose and schedule - Who actually benefits

Rapamycin (sirolimus) is approved as a medicine in Germany, but only for specific uses: - Immune suppression after kidney transplant - Lymphangioleiomyomatosis (LAM, a rare lung disease) - Some vascular malformations (off-label)

Longevity is not an approved use. Any prescription for it counts as off-label. That is legally allowed, but the doctor carries more liability and has to counsel you more carefully.

What that means in practice: - Statutory health insurance only pays for rapamycin for approved uses. For longevity, you pay 100 percent yourself. - Cost: 1 mg tablets run about 3 to 6 euros each. At 5 to 6 mg per week, that lands around 60 to 150 euros per month. - Getting a prescription: You need a doctor willing to prescribe off-label. In Germany, very few practices do. The US has online services for this; Germany does not. - Advertising law (HWG): Advertising rapamycin with longevity claims is not allowed.

Importing from countries outside the EU (India, Turkey): a legal grey zone. Personal use often is not prosecuted, but there is no quality control. Not recommended.

For NMN and related grey-zone questions see the [NMN Germany guide](./nmn-deutschland).

If you are seriously thinking about rapamycin for longevity, the only sensible path runs through a doctor.

Which doctor to approach: - Internal medicine specialists with a preventive or longevity angle - Longevity private practices in Munich, Berlin, Hamburg, Frankfurt - Not your standard GP without specific training

Before you go, get clear on: - Your current markers (blood panel, heart and blood vessel risk, metabolic profile) - Any drugs you take that interact with rapamycin (the CYP3A4 list) - Any current or chronic infections - How much risk you are personally willing to take

Reasonable questions to ask: 1. Do you know the current longevity data on rapamycin? 2. Are you willing to prescribe off-label and document it properly? 3. Which lab values would you track? 4. How often should I come back for check-ins? 5. What would make you stop treatment?

A doctor who will not take these questions seriously is not the right partner. A doctor who will prescribe without any questions is not either.